Menogaril, an anthracycline derivative, inhibits DNA topoisomerase II by stabilizing cleavable complexes.

Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes.

Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative.

Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.

Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity.

Ruthenium(II) complexes as apoptosis inducers by stabilizing c-myc G-quadruplex DNA.

Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes.

Interaction of buthionine sulfoximine and the stabilization of DNA-topoisomerase II complexes by doxorubicin.

Drosophila topoisomerase II-DNA interactions are affected by DNA structure.

protein complexes applied to DNA topoisomerase II cleavage sites.

A carboline derivative as a novel mammalian DNA topoisomerase II targeting agent.

Doxorubicin inhibits human DNA topoisomerase I.

Histone H1 inhibits eukaryotic DNA topoisomerase I.

Developmental regulation of Drosophila DNA topoisomerase II.

Catalytic function of DNA topoisomerase II.

Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives.

Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.

Topoisomerase II minimizes DNA entanglements by proofreading DNA topology after DNA strand passage.

Drug-induced conformational population shifts in topoisomerase-DNA ternary complexes.

Immunodetection of human topoisomerase I-DNA covalent complexes.

Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species: role of DNA breaks.

Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells.

Anticancer activity and DNA-binding investigations of the Cu(II) and Ni(II) complexes with coumarin derivative.

Ternary interactions of spermine with DNA: 4'-epiadriamycin and other DNA: anthracycline complexes.

YM155 inhibits topoisomerase function.

Suggest Documents

Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes.

Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative.

Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.

Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity.

Ruthenium(II) complexes as apoptosis inducers by stabilizing c-myc G-quadruplex DNA.

Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes.

Interaction of buthionine sulfoximine and the stabilization of DNA-topoisomerase II complexes by doxorubicin.

Drosophila topoisomerase II-DNA interactions are affected by DNA structure.

protein complexes applied to DNA topoisomerase II cleavage sites.

A carboline derivative as a novel mammalian DNA topoisomerase II targeting agent.

Doxorubicin inhibits human DNA topoisomerase I.

Histone H1 inhibits eukaryotic DNA topoisomerase I.

Developmental regulation of Drosophila DNA topoisomerase II.

Catalytic function of DNA topoisomerase II.

Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives.

Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.

Topoisomerase II minimizes DNA entanglements by proofreading DNA topology after DNA strand passage.

Drug-induced conformational population shifts in topoisomerase-DNA ternary complexes.

Immunodetection of human topoisomerase I-DNA covalent complexes.

Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species: role of DNA breaks.

Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells.

Anticancer activity and DNA-binding investigations of the Cu(II) and Ni(II) complexes with coumarin derivative.

Ternary interactions of spermine with DNA: 4'-epiadriamycin and other DNA: anthracycline complexes.

YM155 inhibits topoisomerase function.

Menogaril, an anthracycline derivative, inhibits DNA topoisomerase II by stabilizing cleavable complexes.

Recommend Documents

Follow Us